I 
119TH CONGRESS 
1ST SESSION H. R. 3029 
To amend the Research and Development, Competition, and Innovation Act 
to support nucleic acid screening, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 28, 2025 
Ms. SALINAS (for herself and Mr. MCCORMICK) introduced the following bill; 
which was referred to the Committee on Science, Space, and Technology 
A BILL 
To amend the Research and Development, Competition, and 
Innovation Act to support nucleic acid screening, and 
for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited ‘‘Nucleic Acid Standards for 
Biosecurity Act’’. 
SEC. 2. SUPPORTING NUCLEIC ACID SCREENING. 
Section 10221 of the Research and Development, 
Competition, and Innovation Act (42 U.S.C. 18931; en-
acted as part of title II of division B of Public Law 117– 
167) is amended— 
VerDate Sep 11 2014 
09:00 May 06, 2025
Jkt 000000
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H3029.IH
H3029
mprince on LAP1J3WLY3PROD with $$_JOB
(1) in subsection (a)(1)— 
(A) in subparagraph (C), by striking 
‘‘and’’ after the semicolon; 
(B) by redesignating subparagraph (D) as 
subparagraph (E); and 
(C) by inserting after subparagraph (C) 
the following new subparagraph: 
‘‘(D) best practices, guidelines, and tech-
nical standards for risk management associated 
with engineering biology and biomanufacturing, 
including risks associated with the use of artifi-
cial intelligence; and’’; 
(2) by redesignating subsections (b) and (c) as 
subsections (c) and (d), respectively; and 
(3) by inserting after subsection (a) the fol-
lowing new subsection: 
‘‘(b) NUCLEIC ACID SYNTHESIS SCREENING TOOLS 
AND STANDARDS.— 
‘‘(1) IN GENERAL.—The Director, in consulta-
tion with heads of Federal agencies the Director 
considers appropriate, shall carry out measurement 
research to support the development and improve-
ment of best practices and technical standards for 
biosecurity measures related to nucleic acid syn-
thesis, including the following: 
VerDate Sep 11 2014 
09:00 May 06, 2025
Jkt 000000
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H3029.IH
H3029
mprince on LAP1J3WLY3PROD with $$_JOB
‘‘(A) Testing to improve the accuracy, effi-
cacy, and reliability of screening for nucleic acid 
synthesis. 
‘‘(B) Best practices, including security and 
access controls, for operational security and 
managing sequence-of-concern databases to 
support such screening. 
‘‘(C) Technical implementation guidance to 
ensure such screening is effective and secure. 
‘‘(D) Conformity-assessment best practices 
and technical standards. 
‘‘(E) Methods to evaluate the impact and 
effectiveness of the implementation of subpara-
graphs (A) through (D). 
‘‘(2) CONSORTIUM.—In carrying out this sub-
section, the Director shall convene a consortium of 
stakeholders, including industry, institutions of high-
er education, nonprofit organizations, and customers 
to carry out the following: 
‘‘(A) Develop and periodically update con-
sensus priorities and best practices, as appro-
priate, for synthetic nucleic acid procurement 
screening mechanisms. 
‘‘(B) Develop roadmaps to inform the ac-
tivities carried out under paragraph (1). 
VerDate Sep 11 2014 
09:00 May 06, 2025
Jkt 000000
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H3029.IH
H3029
mprince on LAP1J3WLY3PROD with $$_JOB
‘‘(3) REPORT.—Not later than 18 months after 
the first meeting of the consortium under paragraph 
(2), the Director shall submit to the Committee on 
Commerce, Science, and Transportation of the Sen-
ate and the Committee on Science, Space, and Tech-
nology of the House of Representatives a report 
summarizing the findings of the consortium. 
‘‘(4) AUTHORIZATION OF APPROPRIATIONS.—Of 
the funds authorized to be appropriated for the Na-
tional Institute of Standards and Technology pursu-
ant to this section for scientific and technical re-
search and services laboratory activities, there is au-
thorized to be appropriated $5,000,000 for each of 
fiscal years 2026 through 2030 to carry out this 
subsection.’’. 
Æ 
VerDate Sep 11 2014 
09:00 May 06, 2025
Jkt 000000
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\H3029.IH
H3029
mprince on LAP1J3WLY3PROD with $$_JOB